Policy Implications of Pharmaceutical Importation for U.S. Consumers

March 7, 2007

253 SR

Majority Statement

  • Byron L. Dorgan

    Senator

Witness Panel 1

  • Dr. Randall Lutter

    Acting Deputy Commissioner for Policy
    Food and Drug Administration

Witness Panel 2

  • Mr. William Schultz

    Partner
    Zuckerman Spaeder LLP
  • Dr. John Vernon

    Assistant Professor, Department of Finance
    University of Connecticut School of Business
  • Hon. Billy Tauzin

    CEO
    PhRMA
  • Ms. Nelda Barnett

    Member, Board of Directors
    AARP
  • Dr. Stephen Schondelmeyer

    Professor and Head, Department of Pharmaceutical Care & Health Systems
    University of Minnesota, College of Pharmacy